R Millon

2.4k total citations
32 papers, 1.9k citations indexed

About

R Millon is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, R Millon has authored 32 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Molecular Biology, 11 papers in Oncology and 10 papers in Cancer Research. Recurrent topics in R Millon's work include RNA modifications and cancer (9 papers), Cancer-related gene regulation (6 papers) and RNA and protein synthesis mechanisms (5 papers). R Millon is often cited by papers focused on RNA modifications and cancer (9 papers), Cancer-related gene regulation (6 papers) and RNA and protein synthesis mechanisms (5 papers). R Millon collaborates with scholars based in France, United States and Australia. R Millon's co-authors include Joseph Abecassis, Bohdan Wasylyk, M. Eber, D Müller, G. Bronner, A Engelmann, Danièle Muller, David S. Rickman, Emilie Thomas and Aurélien de Reyniès and has published in prestigious journals such as PLoS ONE, Biochemistry and Oncogene.

In The Last Decade

R Millon

32 papers receiving 1.9k citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
R Millon 1.1k 874 768 264 197 32 1.9k
Joseph Abecassis 1.6k 1.5× 1.2k 1.4× 1.1k 1.4× 383 1.5× 241 1.2× 57 2.9k
Daniel Chua 823 0.8× 671 0.8× 449 0.6× 171 0.6× 187 0.9× 28 1.5k
Pinaki Bose 1.0k 1.0× 728 0.8× 357 0.5× 109 0.4× 227 1.2× 42 1.8k
Loren S. Michel 1.6k 1.5× 1.5k 1.7× 454 0.6× 347 1.3× 441 2.2× 72 2.9k
Takashi Imai 914 0.9× 505 0.6× 345 0.4× 43 0.2× 444 2.3× 78 2.0k
Josephine Mun Yee Ko 831 0.8× 491 0.6× 443 0.6× 35 0.1× 185 0.9× 63 1.4k
Adrian Biddle 887 0.8× 985 1.1× 557 0.7× 41 0.2× 172 0.9× 27 1.7k
Kou-Juey Wu 2.2k 2.1× 1.1k 1.3× 1.2k 1.5× 30 0.1× 389 2.0× 25 3.0k
Eberhard Korsching 879 0.8× 578 0.7× 739 1.0× 24 0.1× 346 1.8× 66 1.8k
Iris Eke 1.0k 1.0× 886 1.0× 460 0.6× 71 0.3× 374 1.9× 52 2.1k

Countries citing papers authored by R Millon

Since Specialization
Citations

This map shows the geographic impact of R Millon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by R Millon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites R Millon more than expected).

Fields of papers citing papers by R Millon

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by R Millon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by R Millon. The network helps show where R Millon may publish in the future.

Co-authorship network of co-authors of R Millon

This figure shows the co-authorship network connecting the top 25 collaborators of R Millon. A scholar is included among the top collaborators of R Millon based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with R Millon. R Millon is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ganguli‐Indra, Gitali, Christine Wasylyk, Xiaobo Liang, et al.. (2009). CTIP2 Expression in Human Head and Neck Squamous Cell Carcinoma Is Linked to Poorly Differentiated Tumor Status. PLoS ONE. 4(4). e5367–e5367. 24 indexed citations
2.
Jung, Alain C., Jenny Briolat, R Millon, et al.. (2009). Biological and clinical relevance of transcriptionally active human papillomavirus (HPV) infection in oropharynx squamous cell carcinoma. International Journal of Cancer. 126(8). 1882–1894. 172 indexed citations
3.
Rickman, David S., R Millon, Aurélien de Reyniès, et al.. (2008). Prediction of future metastasis and molecular characterization of head and neck squamous-cell carcinoma based on transcriptome and genome analysis by microarrays. Oncogene. 27(51). 6607–6622. 119 indexed citations
4.
Muller, Danièle, R Millon, Sally Theobald, et al.. (2006). Cyclin L1 (CCNL1) gene alterations in human head and neck squamous cell carcinoma. British Journal of Cancer. 94(7). 1041–1044. 16 indexed citations
5.
Carles, Annaïck, R Millon, Anne Cromer, et al.. (2005). Head and neck squamous cell carcinoma transcriptome analysis by comprehensive validated differential display. Oncogene. 25(12). 1821–1831. 99 indexed citations
6.
Seghatoleslam, Atefeh, Alberto Zambrano, R Millon, et al.. (2005). Analysis of a novel human gene, LOC92912, over-expressed in hypopharyngeal tumours. Biochemical and Biophysical Research Communications. 339(1). 422–429. 19 indexed citations
7.
Millon, R, et al.. (2004). Loss of HOP tumour suppressor expression in head and neck squamous cell carcinoma. British Journal of Cancer. 91(2). 258–261. 18 indexed citations
8.
Lapouge, Gaëlle, R Millon, David W.M. Muller, et al.. (2004). Cisplatin-induced genes as potential markers for thyroid cancer. Cellular and Molecular Life Sciences. 62(1). 53–64. 18 indexed citations
10.
Cromer, Anne, Annaïck Carles, R Millon, et al.. (2003). Identification of genes associated with tumorigenesis and metastatic potential of hypopharyngeal cancer by microarray analysis. Oncogene. 23(14). 2484–2498. 224 indexed citations
11.
Millon, R, J. Christopher Young, Anne Cromer, et al.. (2003). Differential expression profiling of head and neck squamous cell carcinoma (HNSCC). British Journal of Cancer. 89(10). 1940–1949. 64 indexed citations
12.
Millon, R, D Müller, Iman J. Schultz, et al.. (2001). Loss of MDM2 expression in human head and neck squamous cell carcinomas and clinical significance. Oral Oncology. 37(8). 620–631. 24 indexed citations
13.
Parker, Fabienne, et al.. (2001). G3BP is overexpressed in human tumors and promotes S phase entry.. Cancer Letters. 162(2). 213–221. 75 indexed citations
14.
Barberi‐Heyob, Muriel, et al.. (2000). Bcl-2/Bax protein ratio predicts 5-fluorouracil sensitivity independently of p53 status. British Journal of Cancer. 83(10). 1380–1386. 66 indexed citations
16.
Müller, D, R Millon, Michel Velten, et al.. (1997). Amplification of 11q13 DNA markers in head and neck squamous cell carcinomas: Correlation with clinical outcome. European Journal of Cancer. 33(13). 2203–2210. 52 indexed citations
17.
Broët, Philippe, H Magdelénat, J Delarue, et al.. (1996). Prognostic value of steroid receptors after long-term follow-up of 2257 operable breast cancers. British Journal of Cancer. 73(12). 1545–1551. 114 indexed citations
18.
Millon, R, A Engelmann, G. Bronner, et al.. (1994). Frequent amplification of 11q13 DNA markers is associated with lymph node involvement in human head and neck squamous cell carcinomas. European Journal of Cancer Part B Oral Oncology. 30(2). 113–120. 74 indexed citations
19.
Müller, D, Richard Breathnach, A Engelmann, et al.. (1991). Expression of collagenase‐related metalloproteinase genes in human lung or head and neck tumours. International Journal of Cancer. 48(4). 550–556. 189 indexed citations
20.
Millon, R, et al.. (1989). Modulation of human breast cancer cell adhesion by estrogens and antiestrogens. Clinical & Experimental Metastasis. 7(4). 405–415. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026